Back to Results
First PageMeta Content
Pfizer / Gabapentin / Off-label use / Pharmaceutical industry / Food and Drug Administration / Medical prescription / Prescription medication / PharmedOut / Parke-Davis / Pharmacology / Pharmaceutical sciences / Medicine


Office of the Attorney General Paul G. Summers NEWS RELEASE FOR IMMEDIATE RELEASE Sept. 14, 2005
Add to Reading List

Document Date: 2011-07-20 17:26:04

Open Document

File Size: 30,17 KB

Share Result on Facebook

Company

Pfizer Inc. / Warner-Lambert / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

pharmaceutical company resolving allegations / corrective advertising program / /

MedicalCondition

seizure disorders / epileptic seizures / /

Organization

Federal Drug Administration / office of the Attorney General Paul G. Summers NEWS RELEASE FOR IMMEDIATE RELEASE / /

Person

Paul G. Summers / Sharon Curtis-Flair / /

/

Position

Drug Company Agreement Attorney General / Governor / Attorney General / Attorneys General / /

Product

Neurontin / Federal Drug / /

ProvinceOrState

Texas / Vermont / Ohio / Oregon / Florida / North Carolina / California / New York / /

URL

www.publichealthtrust.org.www.naag.gov / /

SocialTag